This finding raises a clinical question regarding the possibility of targeting P2X4 to modulate the immune response that contributes to hepatitis C virus-induced hepatocellular carcinoma, which warrants further investigation to understand the role of P2X4 in hepatitis C virus-induced hepatocellular carcinoma pathology. The gene discussed is P2RX4; the disease is hepatocellular carcinoma.